comparemela.com

Latest Breaking News On - Market lineage - Page 1 : comparemela.com

North America Dominates the Global Gabapentin Market with Developed Healthcare System and High Adopt

DUBLIN (BUSINESS WIRE) The "Gabapentin Market Size, Share & Trends Analysis Report By Dosage Form (Tablet, Capsule, Oral Solution), By Type (Generic, Branded), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.The glob.

United-states
America
Laura-wood
Aurobindo-pharma
Asia-pacific
Ascend-laboratories
Bp-pharmaceuticals-laboratories-company
Glenmark-pharmaceuticals
Arbor-pharmaceuticals-inc
Cipla-united-states-inc
Office-hours-call
Zydus-pharmaceuticals-inc

Emergence of Multidrug-Resistant Strains Steers Global Tuberculosis Therapeutics Market Towards $2.9

DUBLIN (BUSINESS WIRE) The "Tuberculosis Therapeutics Market Size, Share & Trends Analysis Report By Disease Type (Active TB, Latent TB), By Therapy, By Route Of Administration, By Dosage Form, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's.

Eli-lilly
Laura-wood
Public-companies
Route-of-administration-business-analysis
E-st-office-hours-call
Sun-pharmaceutical-industries-ltd
Roche-ltd
Key-company-market-share-analysis
Office-hours-call
Johnson-services-inc
Pfizer-inc
Teva-pharmaceutical-industries-ltd

Global Bronchodilators Market Report 2023: Sector is Expected to Reach $28.75 Billion by 2030 at a C

DUBLIN (BUSINESS WIRE) The "Bronchodilators Market Size, Share & Trends Analysis Report By Disease (Asthma, COPD), By Route Of Administration (Inhalable, Oral), By Drug Class (Beta-Adrenergic, Anticholinergics), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offeri.

United-states
America
American
Laura-wood
Company-profiles
Astrazeneca
Glenmark-pharmaceuticals
Cipla-inc
Teva-pharmaceutical-industries-ltd
Merck-co-inc
Administration-inhalable
E-st-office-hours-call

vimarsana © 2020. All Rights Reserved.